Cargando…

Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer

BACKGROUND: The Gleason score is an essential tool in the decision to treat localized prostate cancer. However, experienced pathologists can classify Gleason score differently than do low-volume pathologists, and this may affect the treatment decision. This study sought to assess the impact of patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usón, Pedro Luiz Serrano, Macarenco, Ricardo Silvestre e Silva, Oliveira, Fernando Nunes, Smaletz, Oren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672998/ https://www.ncbi.nlm.nih.gov/pubmed/29147082 http://dx.doi.org/10.1177/1179555717740130

Ejemplares similares

Castration-resistant prostate cancer: systemic therapy in 2012
por: Maluf, Fernando C., et al.
Publicado: (2012)

Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered
por: Usón, Pedro Luiz Serrano, et al.
Publicado: (2015)

Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis
por: Carneiro, Arie, et al.
Publicado: (2017)

Current management and future directions in the treatment of advanced renal cell carcinoma–a latin american perspective: 10 years in review
por: Smaletz, Oren
Publicado: (2015)

Decision making in local therapy for breast cancer
por: Morrow, Monica
Publicado: (2007)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

How much can improved molecular and pathologic discriminants change local therapy?
por: Morrow, Monica
Publicado: (2008)

The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies
por: Usón, Pedro Luiz Serrano, et al.
Publicado: (2020)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2023)

Prostate cancer recurrence in vas deferens – fusion image guide as an important tool in dignosis
por: Valle, Leonardo Guedes Moreira, et al.
Publicado: (2018)

Investigation of nerve fibers in the skin by biopsy: technical aspects, indications, and contribution to diagnosis of small-fiber neuropathy
por: Raicher, Irina, et al.
Publicado: (2022)

Alternative method of outside–in meniscal repair for anterior horn tears
por: Serrano, Pedro Manuel, et al.
Publicado: (2018)

Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists
por: Shakespeare, Thomas P.
Publicado: (2015)

Automatic localization of the prostatic urethra for image guided radiation therapy
por: Nasser, Nicola J., et al.
Publicado: (2021)

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics
por: Smaletz, Oren, et al.
Publicado: (2016)

Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives
por: Zugman, Miguel, et al.
Publicado: (2022)

Lack of reliability of nanotechnology in the of free plasma DNA in samples of patients with prostate cancer
por: Moreno, Ricardo, et al.
Publicado: (2013)

Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries
por: Khauli, Raja, et al.
Publicado: (2021)

Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
por: Maluf, Fernando Cotait, et al.
Publicado: (2021)

Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs
por: Birgand, Gabriel, et al.
Publicado: (2013)

Brief report: Impact of healthcare quality on prostate specific antigen screening for the early detection of prostate cancer
por: Rezaee, Michael E., et al.
Publicado: (2019)

Recent advances in understanding cholangiocarcinoma
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2020)

Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2019)

COVID-19 Impact on Modern Virtual Pathology Education: Challenges and Opportunities
por: Azimi Khatibani, Seyed Esmaeil, et al.
Publicado: (2021)

Does attendance at the ECTRIMS congress impact on therapeutic decisions in multiple sclerosis care?
por: Saposnik, Gustavo, et al.
Publicado: (2019)

Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features
por: Zhang, Fang, et al.
Publicado: (2020)

Treatment of cancer patients during the COVID-19 pandemic in the Philippines
por: Ting, Frederic Ivan, et al.
Publicado: (2020)

Work hours as a risk factor for SARS-CoV-2 infections: cardiometabolic and sleep characteristics in rotating shift workers
por: Nascimento, Raiza Aranha, et al.
Publicado: (2022)

Invasive potential of biofilm-forming Staphylococci bovine subclinical mastitis isolates
por: Oliveira, Manuela, et al.
Publicado: (2011)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
por: Matti, A., et al.
Publicado: (2017)

“Budget Impact Analyses”: A Practical Policy Making Tool for Drug Reimbursement Decisions
por: Jamshidi, Hamid Reza, et al.
Publicado: (2014)

The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels
por: Werutsky, Gustavo, et al.
Publicado: (2019)

Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy
por: Testa, Laura, et al.
Publicado: (2021)

Local therapies for breast cancer
por: Exner, Ruth
Publicado: (2017)

A cardiac rehabilitation exercise program potentially inhibits progressive inflammation in patients with severe Chagas cardiomyopathy: A pilot single-arm clinical trial
por: Rodrigues Junior, Luiz Fernando, et al.
Publicado: (2020)

Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
por: Chen, Michael J, et al.
Publicado: (2007)

Sources of Information for Learning and Decision-Making in Men With Localized Prostate Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2020)

Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
por: Nishimura, Ari, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m8kr0l2cgd91vuhce546c84jgs